Kus T - Search Results

1

Evaluation of arrhythmic causes of syncope: correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping.

Lacroix D, Dubuc M, Kus T, Savard P, Shenasa M, Nadeau R. Lacroix D, et al. Among authors: kus t. Am Heart J. 1991 Nov;122(5):1346-54. doi: 10.1016/0002-8703(91)90576-4. Am Heart J. 1991. PMID: 1950999

2

Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.

Kus T, Campa MA, Nadeau R, Dubuc M, Kaltenbrunner W, Shenasa M. Kus T, et al. Am Heart J. 1992 Jan;123(1):82-9. doi: 10.1016/0002-8703(92)90750-p. Am Heart J. 1992. PMID: 1729853

3

Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time.

Kus T, Dubuc M, Lambert C, Shenasa M. Kus T, et al. J Am Coll Cardiol. 1990 Nov;16(5):1229-37. doi: 10.1016/0735-1097(90)90558-7. J Am Coll Cardiol. 1990. PMID: 2229772 Free article. Clinical Trial.

4

Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.

Dubuc M, Kus T, Campa MA, Lambert C, Rosengarten M, Shenasa M. Dubuc M, et al. Among authors: kus t. Am Heart J. 1989 Feb;117(2):370-6. doi: 10.1016/0002-8703(89)90781-3. Am Heart J. 1989. PMID: 2644795 Clinical Trial.

5

Body surface potential distributions during idiopathic ventricular tachycardia.

Klug D, Ferracci A, Molin F, Dubuc M, Savard P, Kus T, Hélie F, Cardinal R, Nadeau R. Klug D, et al. Among authors: kus t. Circulation. 1995 Apr 1;91(7):2002-9. doi: 10.1161/01.cir.91.7.2002. Circulation. 1995. PMID: 7895359

6

Pace mapping using body surface potential maps to guide catheter ablation of accessory pathways in patients with Wolff-Parkinson-White syndrome.

Dubuc M, Nadeau R, Tremblay G, Kus T, Molin F, Savard P. Dubuc M, et al. Among authors: kus t. Circulation. 1993 Jan;87(1):135-43. doi: 10.1161/01.cir.87.1.135. Circulation. 1993. PMID: 8419000

7

Clinical experience with a new software-based antitachycardia pacemaker for recurrent supraventricular and ventricular tachycardias.

Fromer M, Gloor H, Kus T, Shenasa M. Fromer M, et al. Among authors: kus t. Pacing Clin Electrophysiol. 1990 Jul;13(7):890-9. doi: 10.1111/j.1540-8159.1990.tb02126.x. Pacing Clin Electrophysiol. 1990. PMID: 1695746

8

Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.

Kus T, Costi P, Dubuc M, Shenasa M. Kus T, et al. Am Heart J. 1990 Oct;120(4):855-63. doi: 10.1016/0002-8703(90)90201-8. Am Heart J. 1990. PMID: 2220538

9

Vasovagal syncope: management with atrioventricular sequential pacing and beta-blockade.

Kus T, Lalonde G, de Champlain J, Shenasa M. Kus T, et al. Can J Cardiol. 1989 Nov-Dec;5(8):375-8. Can J Cardiol. 1989. PMID: 2575013

10

Termination of sustained ventricular tachycardia with a new antitachycardia pacemaker: role of the nonautomatic mode to follow pacemaker function.

Fromer M, Kus T, Page P, Shenasa M. Fromer M, et al. Among authors: kus t. Can J Cardiol. 1989 Jan-Feb;5(1):42-6. Can J Cardiol. 1989. PMID: 2920305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters